Skip to main content
OpenTrials
Completed

NCT Number: NCT04046926

Relapse in Anorexia Nervosa. A Cohort Study

The hospitalization in patients with anorexia nervosa has often a short-term success, as weight is restored to a healthy level, but high percentage of patients relapse during the first year following the discharge. Starting from the observation that the relapse rate is lower in outpatient than in inpatient settings, the investigators hypothesized that the reason of this difference is the nature of inpatient treatment and post-inpatient therapy. For this reason, different procedures and strategies have been implemented during hospitalization to reduce the relapse after discharge. The aim of the study was to assess the time and the percentage of relapse after inpatient discharge and at follow-up.

Completed

Looking for future studies?

Notify Me

Key information

Age range

13 year–65 year

Sex eligibility

Female

Study type

Observational

Primary location

Department of Eating and Weight Disorders, Villa Garda Hospital

Garda, Italy, 37016

About this study

Anorexia nervosa is considered one of the most difficult to treat mental disorders and often treatment outcomes are unsatisfactory. Outpatient treatment is the ideal choice for the treatment of anorexia nervosa, but a large subgroup of patients (50-60%) does not respond to outpatient treatments and need more intensive care, such as hospital rehabilitation. The hospitalization has often a short-term success, as weight is restored to a healthy level, but high percentage of patients relapse during the first year following the discharge. Strategies to limit the post-hospitalization relapse rate are now focused on assessing the effectiveness of different treatments given after discharge. Our group, after evaluating the results of a controlled study, used another strategy. Starting from the observation that the relapse rate is lower in outpatient than in inpatient settings, the investigators hypothesized that the reason of this difference is the nature of inpatient treatment and post-inpatient therapy. For this reason, different procedures and strategies have been implemented during hospitalization to reduce the relapse after discharge.

The primary outcome of interest is the proportion of patients who relapse after discharge from hospitalization. For the calculation of the sample size a 95% confidence interval was established, an expected prevalence of 40% and a desired accuracy of 10%. Based on these premises, it is necessary to have a group of "completers" at 60 weeks of follow-up of 92 patients. To calculate the initial sample needed to generate 92 patients at 60 weeks of follow-up, the investigators considered the attrition rate during treatment (set at 13%) and a subsequent attrition rate at follow-ups (set at 10%). This calculation produces a result of an initial sample of 118 patients.

The frequency and time of relapse will be evaluated using Kaplan-Meier survival analysis. Cox proportional hazards regression analysis will be used to examine the role of predictive variables in predicting time to relapse. Univariate Cox regressions and multivariate Cox regressions will be used to evaluate the potentially predictive variables at baseline, during the treatment process, at the end of therapy and during post-discharge.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Female
  • Age >= 13 years and <= 65 years
  • Meeting diagnostic criteria for anorexia nervosa at inpatient admission
  • Full response (i.e., Body Mass Index (BMI) >= 18.5 kg/m2 and Eating Disorder Examination Questionnaire (EDE-Q) global score < 2.77) at discharge
  • Written informed consent

Exclusion criteria

  • Acute psychotic disorders
  • Active substance abuse
  • Meeting diagnostic criteria for bulimia nervosa
  • Medical complication that may hamper the interpretation of results (medical condition that causes weight changes)
  • Absence of medical treatment (drugs) that may hamper the interpretation of results
  • Pregnancy or plan to get pregnant

Treatment and study plan

Primary outcomes

  1. Good BMI outcome

    Time frame: 40 weeks after inpatient admission (corresponding to 20 weeks after discharge)

    Body Mass Index >= 18.5 kg/m2

Secondary outcomes

  1. Relapse

    Time frame: 40 weeks after inpatient admission (corresponding to 20 weeks after discharge)

    To evaluate the relapse, investigators need to consider patients with full response at discharge of inpatient treatment (i.e. after 20 weeks from admission) that relapse during the following 20 weeks (i.e 40 weeks after inpatient admission).

    So, the criteria for the relapse are:

    • full response after 20 weeks of inpatient treatment AND
    • underweight BMI (i.e. BMI < 18.5 kg/m2) AND/OR
    • high level of eating disorder psychopathology (i.e. EDE-Q ≥ 2.77)
  2. Full Response

    Time frame: 40 weeks after inpatient admission (corresponding to 20 weeks after discharge)

    To evaluate the full response in underweight eating disorder patients the investigators need to evaluate both the reaching a non-underweight BMI and an eating disorder psychopathology similar to non-clinical cases.

    To evaluate the eating disorder psychopathology the investigators used the Eating Disorder Examination Questionnaire (EDE-Q). The EDE-Q global score range from 0 to 6.

    The criteria for the Full Response are the following:

    • Body Mass Index >= 18.5 kg/m2 AND
    • Eating Disorder Examination Questionnaire (EDE-Q) global score < 2.77.

Sponsors and collaborators

Lead sponsor

Villa Garda Hospital

Other

Registry information

Official study title

Relapse in Anorexia Nervosa: a Prospective Longitudinal Study

Important dates

Study start
2020
Primary completion
2024
Study completion
2024
First posted
Aug 6, 2019
Registry last updated
Sep 24, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.